The H3A Diabetes Study: A multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa. (Field Data collection 2015-2018)
South Africa, 2015 - 2018
Get Microdata
Reference ID
H3A.Clinical.and.Population.Dataset.2021.v1
Producer(s)
Motala Ayesha†, Adebamowo Clement, Balde Naby, Kaleebu Pontiano, Kapiga Saidi, Levitt Naomi, Mayige Mary, McCarthy Mark, Nyirenda Moffat , Heyderman Robert, Oli John, Rotimi Charles, Sandhu Manjinder, Sobngwi Eugene, Smeeth Liam, Kenneth Ekoru, † Lead Principal investigator
Metadata
Created on
May 12, 2021
Last modified
May 12, 2021
Page views
74579
Downloads
296
- Data files
-
H3A.Clinical
and Population
Dataset.2021.v1
Number of pills taken during the past month of first prescription (PrMedTkn1M)
Data file: H3A.Clinical and Population Dataset.2021.v1
Overview
Valid:
54263
Invalid:
0
Type:
Discrete
Decimal:
0
Width:
10
Range:
0 - 999
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0 | 281 |
0.5%
|
|
| 0.5 | 11 |
0%
|
|
| 1 | 7593 |
14%
|
|
| 2 | 10185 |
18.8%
|
|
| 3 | 945 |
1.7%
|
|
| 4 | 428 |
0.8%
|
|
| 5 | 7 |
0%
|
|
| 6 | 17 |
0%
|
|
| 7 | 7 |
0%
|
|
| 8 | 3 |
0%
|
|
| 9 | 5 |
0%
|
|
| 10 | 6 |
0%
|
|
| 12 | 13 |
0%
|
|
| 14 | 40 |
0.1%
|
|
| 15 | 35 |
0.1%
|
|
| 16 | 5 |
0%
|
|
| 17 | 5 |
0%
|
|
| 20 | 46 |
0.1%
|
|
| 21 | 24 |
0%
|
|
| 22 | 17 |
0%
|
|
| 23 | 6 |
0%
|
|
| 24 | 16 |
0%
|
|
| 26 | 21 |
0%
|
|
| 27 | 10 |
0%
|
|
| 28 | 457 |
0.8%
|
|
| 29 | 3 |
0%
|
|
| 30 | 825 |
1.5%
|
|
| 32 | 5 |
0%
|
|
| 34 | 9 |
0%
|
|
| 35 | 7 |
0%
|
|
| 36 | 9 |
0%
|
|
| 38 | 3 |
0%
|
|
| 40 | 6 |
0%
|
|
| 42 | 16 |
0%
|
|
| 45 | 8 |
0%
|
|
| 46 | 9 |
0%
|
|
| 48 | 13 |
0%
|
|
| 50 | 13 |
0%
|
|
| 52 | 8 |
0%
|
|
| 53 | 5 |
0%
|
|
| 54 | 26 |
0%
|
|
| 56 | 808 |
1.5%
|
|
| 57 | 4 |
0%
|
|
| 58 | 21 |
0%
|
|
| 59 | 5 |
0%
|
|
| 60 | 1037 |
1.9%
|
|
| 61 | 5 |
0%
|
|
| 65 | 4 |
0%
|
|
| 84 | 59 |
0.1%
|
|
| 90 | 41 |
0.1%
|
|
| 112 | 36 |
0.1%
|
|
| 120 | 30 |
0.1%
|
|
| 133 | 4 |
0%
|
|
| 140 | 11 |
0%
|
|
| 150 | 28 |
0.1%
|
|
| 168 | 10 |
0%
|
|
| 180 | 13 |
0%
|
|
| 196 | 8 |
0%
|
|
| 210 | 7 |
0%
|
|
| 224 | 8 |
0%
|
|
| 240 | 9 |
0%
|
|
| 250 | 4 |
0%
|
|
| 280 | 3 |
0%
|
|
| 300 | 12 |
0%
|
|
| 336 | 4 |
0%
|
|
| 364 | 4 |
0%
|
|
| 442 | 4 |
0%
|
|
| 504 | 2 |
0%
|
|
| 555 | Skipped | 29147 |
53.7%
|
| 560 | 2 |
0%
|
|
| 600 | 4 |
0%
|
|
| 728 | 3 |
0%
|
|
| 777 | No answer | 48 |
0.1%
|
| 840 | 8 |
0%
|
|
| 888 | Don't know | 645 |
1.2%
|
| 952 | 5 |
0%
|
|
| 999 | Not Applicable | 1072 |
2%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.